Association of US centers for medicare and medicaid services hospital 30-day risk-standardized readmission metric with care quality and outcomes after acute myocardial infarction

JAMA Cardiology

Volumn 2, Issue 7, 2017, Pages 723-731

  Pandey, Ambarish ^a   Golwala, Harsh ^b   Hall, Hurst M ^a   Wang, Tracy Y ^c   Lu, Di ^c   Xian, Ying ^c,d   Chiswell, Karen ^c   Joynt, Karen E ^b   Goyal, Abhinav ^e   Das, Sandeep R ^a   Kumbhani, Dharam ^a   Julien, Howard ^f   Fonarow, Gregg C ^g,h   De Lemos, James A ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Columbia University School of Medicine ^*  (United States)

^g UCLA MEDICAL CENTER   (United States)

^h JAMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGE; AGED; ALL CAUSE MORTALITY; ARTICLE; BLACK PERSON; BLEEDING; CARDIOVASCULAR MORTALITY; CLINICAL FEATURE; CLINICAL OUTCOME; COHORT ANALYSIS; DISEASE REGISTRY; FEMALE; HEALTH CARE QUALITY; HEART FAILURE; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; MORTALITY RISK; OBSERVATIONAL STUDY; PATIENT CARE; PATIENT RISK; PRIORITY JOURNAL; UNITED STATES; GOVERNMENT; HEART INFARCTION; HEART MUSCLE REPERFUSION; HEART REHABILITATION; HEART STROKE VOLUME; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; PATIENT REFERRAL; PERCUTANEOUS CORONARY INTERVENTION; REGISTER; SMOKING CESSATION; STATISTICS AND NUMERICAL DATA;

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ASPIRIN; CARDIAC REHABILITATION; CENTERS FOR MEDICARE AND MEDICAID SERVICES (U.S.); FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT READMISSION; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; PROCESS ASSESSMENT (HEALTH CARE); QUALITY INDICATORS, HEALTH CARE; QUALITY OF HEALTH CARE; REFERRAL AND CONSULTATION; REGISTRIES; SMOKING CESSATION; STROKE VOLUME; UNITED STATES;

EID: 85031672770     PISSN: 23806583     EISSN: 23806591     Source Type: Journal    
DOI: 10.1001/jamacardio.2017.1143     Document Type: Article

References (32)

1. Fingar K,Washington R. Trends in Hospital Readmissions for Four High-Volume Conditions, 2009-2013: Statistical Brief No. 196: Healthcare Cost and Utilization Project (HCUP). Rockville, MD: Agency for Healthcare Research and Quality; 2006.
2. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009;360 (14):1418-1428.
3. Hospital Readmissions Reduction Programs (HRRP). 76 Fed Reg 51660. August 18, 2011.
4. Centers for Medicare and Medicaid Services (CMS), HHS. Medicare program; hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system and Fiscal Year 2014 rates; quality reporting requirements for specific providers; hospital conditions of participation; payment policies related to patient status: final rules. Fed Regist. 2013;78(160):50495-51040.
5. DeVore AD, Hammill BG, Hardy NC, Eapen ZJ, Peterson ED, Hernandez AF. Has public reporting of hospital readmission rates affected patient outcomes? analysis of Medicare claims data. J Am Coll Cardiol. 2016;67(8):963-972.
6. Joynt KE, Jha AK. Thirty-day readmissions: truth and consequences. N Engl J Med. 2012;366(15): 1366-1369.
7. Joynt KE, Jha AK. A path forward on Medicare readmissions. N Engl J Med. 2013;368(13):1175-1177.
8. Bradley EH, Herrin J, Elbel B, et al. Hospital quality for acutemyocardial infarction: correlation among process measures and relationship with short-term mortality. JAMA. 2006;296(1):72-78.
9. Granger CB, Steg PG, Peterson E, et al; GRACE Investigators. Medication performance measures and mortality following acute coronary syndromes. Am J Med. 2005;118(8):858-865.
10. Peterson ED, Roe MT, Mulgund J, et al. Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA. 2006;295(16):1912-1920.
11. Peterson ED, RoeMT, Rumsfeld JS, et al. A call to ACTION (Acute Coronary Treatment and Intervention OutcomesNetwork): a national effort to promote timely clinical feedback and support continuous quality improvement for acute myocardial infarction. Circ Cardiovasc Qual Outcomes. 2009;2(5):491-499.
12. Hammill BG, Hernandez AF, Peterson ED, Fonarow GC, Schulman KA, Curtis LH. Linking inpatient clinical registry data to Medicare claims data using indirect identifiers. Am Heart J. 2009; 157(6):995-1000.
13. Goyal A, de Lemos JA, Peng SA, et al. Association of patient enrollment in Medicare Part D with outcomes after acutemyocardial infarction. Circ Cardiovasc Qual Outcomes. 2015;8 (6):567-575.
14. Centers for Medicare and Medicaid Services. Readmissions Reduction Program (HRRP). https://www.cms.gov/medicare/medicare-fee-for-service-payment/acuteinpatientpps/readmissions-reduction-program.html. Accessed May 16, 2016.
15. Gilman M, Hockenberry JM, Adams EK, Milstein AS, Wilson IB, Becker ER. The financial effect of value-based purchasing and the hospital readmissions reduction program on safety-net hospitals in 2014: a cohort study. Ann Intern Med. 2015;163(6):427-436.
16. QualityNet. Measure methodology reports: readmission measures. https://www.qualitynet.org/dcs/ContentServer?c=Pagepagename =QnetPublic%2FPage%2FQnetTier4cid =1219069855841. Accessed May 16, 2016.
17. Subherwal S, Patel MR, Tang F, et al. Socioeconomic disparities in the use of cardioprotective medications among patients with peripheral artery disease: an analysis of the American College of Cardiology's NCDR PINNACLE Registry. J AmColl Cardiol. 2013;62(1):51-57.
18. Joynt KE, Orav EJ, Jha AK. Thirty-day readmission rates for Medicare beneficiaries by race and site of care. JAMA. 2011;305(7):675-681.
19. Hess CN,Wang TY,McCoy LA, et al. Unplanned inpatient and observation rehospitalizations after acutemyocardial infarction: insights from the Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) Study. Circulation. 2016;133(5):493-501.
20. Tisminetzky M, McManus DD, Erskine N, et al. Thirty-day hospital readmissions in patients with non-ST-segment elevation acutemyocardial infarction. Am J Med. 2015;128(7):760-765.
21. Fischer C, Steyerberg EW, Fonarow GC, Ganiats TG, Lingsma HF. A systematic review and meta-analysis on the association between quality of hospital care and readmission rates in patients with heart failure. Am Heart J. 2015;170(5):1005-1017.e2.
22. Mathews R, Fonarow GC, Li S, et al; National Cardiovascular Data Registry. Comparison of performance on Hospital Compare process measures and patient outcomes between hospitals that do and do not participate in Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines. Am Heart J. 2016;175:1-8.
23. Chin DL, BangH, Manickam RN, Romano PS. Rethinking thirty-day hospital readmissions: shorter intervals might be better indicators of quality of care. Health Aff (Millwood). 2016;35(10):1867-1875.
24. Dharmarajan K, Krumholz HM. Strategies to reduce 30-day readmissions in older patients hospitalized with heart failure and acute myocardial infarction. Curr Geriatr Rep. 2014;3(4): 306-315.
25. Gorodeski EZ, Starling RC, Blackstone EH. Are all readmissions bad readmissions? N Engl J Med. 2010;363(3):297-298.
26. Krumholz HM, Lin Z, Keenan PS, et al. Relationship between hospital readmission and mortality rates for patients hospitalized with acute myocardial infarction, heart failure, or pneumonia. JAMA. 2013;309(6):587-593.
27. Press MJ, Scanlon DP, Ryan AM, et al. Limits of readmission rates in measuring hospital quality suggest the need for added metrics. Health Aff (Millwood). 2013;32(6):1083-1091.
28. Pandey A, Golwala H, Xu H, et al. Association of 30-day readmission metric for heart failure under the hospital readmissions reduction program with quality of care and outcomes. JACC Heart Fail. 2016; 4(12):935-946.
29. Desai NR, Ross JS, Kwon JY, et al. Association between hospital penalty status under the hospital readmission reduction program and readmission rates for target and nontarget conditions. JAMA. 2016;316(24):2647-2656.
30. Zuckerman RB, Sheingold SH, Orav EJ, Ruhter J, Epstein AM. Readmissions, observation, and the hospital readmissions reduction program. N Engl J Med. 2016;374(16):1543-1551.
31. Pub L No. 114-255. 21st Century Cures Act.
32. Messenger JC, Ho KK, Young CH, et al; NCDR Science and Quality Oversight Committee Data QualityWorkgroup. The National Cardiovascular Data Registry (NCDR) Data Quality Brief: the NCDR Data Quality Program in 2012. J AmColl Cardiol. 2012;60(16):1484-1488.